➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Colorcon
Mallinckrodt
Harvard Business School
Moodys

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)


Email this page to a colleague

« Back to Dashboard

Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)

Docket   Get Started Free Date Filed 2015-08-05
Court District Court, D. Delaware Date Terminated 2018-04-24
Cause 35:0145 Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties THE P.F. LABORATORIES INC.
Patents 6,011,020; 6,733,783; 8,114,383; 8,309,060; 8,361,499; 8,529,948; 8,551,520; 8,647,667; 8,808,740; 9,023,401; 9,056,052; 9,060,940; 9,084,816; 9,095,614; 9,095,615; 9,198,863; 9,205,056; 9,486,412; 9,486,413; 9,492,390; 9,492,391; 9,517,236; 9,545,380; 9,572,779; 9,572,804; 9,669,024; 9,675,610; 9,675,611; 9,750,703; 9,763,933; 9,775,809
Attorneys Nicholas J Doyle
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Alvogen Pine Brook LLC
The small molecule drugs covered by the patents cited in this case are   Get Started Free ,   Get Started Free ,   Get Started Free , and   Get Started Free .

Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2017-04-18 175 Hossein Omidian Regarding Invalidity of U.S. Patent Nos. 6,733,783; 8,361,499; 8,551,520; 8,647,667; 9,023,…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware External link to document
2017-04-19 177 Jacobs, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Mayersohn, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Muzzio, Ph.D. Concerning the Invalidity of U.S. Patent Nos. 8,529,948; 8,309,060; 9,084,816; 9,095,614…Ryu, Ph.D. Concerning the Indefiniteness of U.S. Patent Nos. 9,198,863 and 8,808,740 filed by Alvogen Pine…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware External link to document
2017-05-10 178 cannot be easily pulverized or crushed. Id. col. 6 11. 20-23. The specification goes on to explain that ….S. Patent Nos. 6,733,783 ("the '783 patent"), 8,361,499 ("the '499 patent"…948 patent"), 8,808,740 ("the '740 patent"), 9,056,052 ("the '052 patent"…8,551,520 ("the '520 patent"), 8,647,667 ("the '667 patent"), 9,023,401 ("…quot;the '401 patent), 8,309,060 (''the '060 patent"), 8,529,948 ("the '948 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Mallinckrodt
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.